AG
CDAK

Artal Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Artal Group’s Portfolio CDAK Stock Details CDAK Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$80K Hold
2022
Q3 		$156K Hold
2022
Q2 		$576K Hold
2022
Q1 		$1.25M Hold
2021
Q4 		$2.23M Hold
2021
Q3 		$3.27M Hold
2021
Q2 		$3.71M Hold
2021
Q1 		$3.02M Buy